Sofosvel (Sofosbuvir 400 mg + Velpatasvir 100 mg) – 6 Tablets
$ 85.00
Sofosvel (Sofosbuvir 400 mg + Velpatasvir 100 mg) represents a significant advancement in the treatment of Hepatitis C. Developed by Beacon Pharmaceuticals Ltd., this medication offers a powerful and comprehensive approach to managing and curing Hepatitis C infections, providing new hope for patients worldwide. Supplier Orio Pharma ensures this life-changing medication is accessible globally.
Sofosvel works synergistically to inhibit the replication of HCV. Sofosbuvir targets the NS5B RNA-dependent RNA polymerase, essential for viral RNA replication. Velpatasvir inhibits the NS5A protein, which is crucial for both RNA replication and the assembly of the virus. This dual-action approach disrupts the virus’s lifecycle, leading to a significant reduction in viral load and, ultimately, the eradication of the infection.
Product Feature:
Manufacturer | : Beacon Pharmaceuticals Ltd. |
Indication | : Hepatitis C Virus, Oncology drugs. |
Generic | : Sofosbuvir Velpatasvir |
Formulation | : Tablet |
Pack Size | : 6 Tablets |
Strengths | : 400+100 Mg |
Storage | : Below 30°C |
You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Sofosvel (Sofosbuvir 400 mg + Velpatasvir 100 mg) medicine.
Reviews
There are no reviews yet.